Contesting the C Word: The Diagnosis of DCIS and Women's Resistance Against Overtreatment.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Contesting the C Word: The Diagnosis of DCIS and Women's Resistance Against Overtreatment.
Συγγραφείς: Gu CJ; Department of Sociology, Western Michigan University, Kalamazoo, Michigan, USA.
Πηγή: Sociology of health & illness [Sociol Health Illn] 2026 Feb; Vol. 48 (2), pp. e70145.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 8205036 Publication Model: Print Cited Medium: Internet ISSN: 1467-9566 (Electronic) Linking ISSN: 01419889 NLM ISO Abbreviation: Sociol Health Illn Subsets: MEDLINE
Imprint Name(s): Publication: <2003->: Oxford ; Malden, MA : Blackwell Publishing
Original Publication: Henley-on-Thames ; Boston, Mass. : Routledge & Kegan Paul
Ιατρικοί όροι (MeSH): Breast Neoplasms*/diagnosis , Breast Neoplasms*/therapy , Breast Neoplasms*/psychology , Carcinoma, Intraductal, Noninfiltrating*/diagnosis , Carcinoma, Intraductal, Noninfiltrating*/therapy , Carcinoma, Intraductal, Noninfiltrating*/psychology , Overtreatment*, Humans ; Female ; Middle Aged ; Adult
Περίληψη: DCIS, or ductal carcinoma in situ-also known as Stage 0 breast cancer-accounts for approximately 20 per cent of new breast cancer cases. Although it is noninvasive, treatment typically mirrors that of invasive cancer. Whether DCIS is overtreated remains controversial, even among medical professionals. This study analyses discussions within a Facebook group of women diagnosed with DCIS who have declined the standard of care (SOC). The findings suggest that these women hold contrasting views on cancer risk compared to their healthcare providers. Although doctors focus on the potential for DCIS to progress to invasive cancer, the women emphasise the higher likelihood of nonprogression. Their considerations of alternative treatments are often dismissed by medical professionals, heightening the stress of an already anxiety-inducing diagnosis. This online community provides affirmation and support to those who choose holistic approaches to manage their condition. However, rejecting the SOC shifts the responsibility for healing onto the individual. These women must engage in vigilant self-surveillance, maintain strict healthy lifestyles and uphold an optimistic outlook-demands that require significant physical discipline and emotion work. This case carries important implications for both sociological research and medical practice.
(© 2026 The Author(s). Sociology of Health & Illness published by John Wiley & Sons Ltd on behalf of Foundation for the Sociology of Health & Illness.)
References: BMJ Evid Based Med. 2018 Feb;23(1):1-3. (PMID: 29367314)
Br J Cancer. 2024 Sep;131(5):852-859. (PMID: 38982194)
Sociol Health Illn. 2021 Jan;43(1):58-64. (PMID: 32964516)
J Health Soc Behav. 2010 Dec;51(4):408-23. (PMID: 21131618)
Breast Cancer Manag. 2015 Jan 1;4(1):33-40. (PMID: 25621015)
Sociol Health Illn. 2026 Feb;48(2):e70145. (PMID: 41614315)
N Engl J Med. 2000 Jun 22;342(25):1902-4. (PMID: 10861327)
BMJ Evid Based Med. 2023 Aug;28(4):213-217. (PMID: 36460328)
Patient Educ Couns. 2017 Sep;100(9):1654-1666. (PMID: 28442156)
Sociol Health Illn. 2009 Mar;31(2):278-99. (PMID: 19220801)
J Eval Clin Pract. 2022 Oct;28(5):821-827. (PMID: 34693594)
Soc Sci Med. 2011 Apr;72(8):1374-82. (PMID: 21454003)
Am Soc Clin Oncol Educ Book. 2012;:e40-5. (PMID: 24451829)
Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):93-102. (PMID: 36115740)
J Oncol Pract. 2015 May;11(3):168-70. (PMID: 25804988)
Ann Surg Oncol. 2016 Dec;23(13):4134-4136. (PMID: 27704372)
Breast Cancer Res Treat. 2023 Jun;199(3):415-433. (PMID: 37074481)
Front Public Health. 2023 Jan 12;10:1072708. (PMID: 36711334)
Cancer Treat Res Commun. 2023;35:100706. (PMID: 37058969)
JAMA. 2025 Mar 18;333(11):972-980. (PMID: 39665585)
Sociol Health Illn. 2020 Aug;42 Suppl 1:114-129. (PMID: 31749268)
Contributed Indexing: Keywords: DCIS; biomedicalisation; breast cancer; cancer risk; overtreatment; surveillance medicine
Entry Date(s): Date Created: 20260130 Date Completed: 20260701 Latest Revision: 20260921
Update Code: 20260921
PubMed Central ID: PMC12856781
DOI: 10.1111/1467-9566.70145
PMID: 41614315
Βάση Δεδομένων: MEDLINE